May. 18 at 1:51 PM
Biotech has serious potential to lead this week.
• FDA decisions coming for multiple names
• Prime editing breakthrough just confirmed
• Sector ETFs (XBI/IBB) are gaining steam
• Momentum names already waking up (PRME, ORGO)
Here are a few I’m watching closely:
⸻
$PRME – Reclaiming
$1.60 with volume. Breakout zone is
$1.76–
$1.88. This could trigger a move toward
$2.17 and
$3.18 near term. Chart and catalyst lining up.
The first patient treated with prime editing
$BSEM – Holding up well after the recent sell-off. If it breaks
$12.82 with volume, the room is back toward
$14–15+.
$ADMA – Needs to clear
$20.33 for continuation. Target
$21–22+. Risk under
$19.25.
$ORGO – Broke out of a long consolidation under
$3.10. Volume hit hard late Friday. Room to
$3.50+ if it holds the trend.
$IFRX - Sitting on support around
$1.65. If
$1.72 breaks with volume, this could bounce toward
$1.90–
$2.15. Has a history of sharp squeezes off support.
Also, XRTX and INZY to keep an eye on as well.
